Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

A survey conducted in Canada examined the prevalence of perceived genetic discrimination against patients with Huntington disease ... of differences in their DNA that could affect their health ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial. Pridopidine is an oral agonist of the S1R protein ...

It was previously believed that the Levantine DNA of the Phoenicians spread as far as their famous alphabet, which influenced quite a few languages. DNA analysis of individuals buried in what used ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

Older adults who ... Knowing Your Alzheimer's Risk May Ease Anxiety but Reduce Motivation for Healthy Habits May 7, 2025 — Learning about one's risk for Alzheimer's disease may not lead to ...

For the first time, a federally recognized Indigenous tribe in the U.S. has led research using DNA to show their ancestral history. The Picuris Pueblo, a sovereign nation in New Mexico ...

The Catholic Church has acknowledged one of its priests fathered a child, after his daughter used high-level DNA testing to legally prove her identity in an Australian first. South Australian ...